NCT04458935

Retrospective Case Series of Trans-scleral Cryotherapy for Retinal Hemangioblastoma

CompletedOBSERVATIONAL

Trial Details

Start: 2020-07-02Est. Completion: 2026-06-02

Enrollment target: 25 participants

Locations

National Eye Institute (NEI), Bethesda, Maryland, United States

Other microbiome trials you might be interested in

Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL TrialPhase 2Recruiting

Von Hippel LindauVon Hippel Lindau DiseaseVon Hippel Lindau-Deficient Clear Cell Renal Cell CarcinomaHemangioblastoma (HB) of the Central Nervous System (CNS)PNETRetinal Angiomatous ProliferationPheochromocytoma/ParagangliomaEndolymphatic Sac Tumor

The BELIEVE-VHL Trial is a prospective real-life study designed to evaluate the therapeutic effects, benefits, and adver…

São Paulo, BrazilEst. completion Feb 1, 2026

View Trial →

Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to FollowPhase 2TERMINATED

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.